Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Griffin P. Rodgers, MD, MACP
Researcher Director
National Institute of Diabetes
and Digestive and Kidney Diseases
Building 31, Room 9A52
31 Center Drive
Bethesda, Maryland, United States
Dr. Griffin Rodgers, Director of the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases, is an accomplished clinician, researcher, and mentor, and is a role model.
His research interests include genetic diseases: sickle cell anemia, thalassemia, red cell enzymopathies; clinical evaluation of disease severity; treatment, including pharmacological alteration of gene expression and stem cell transplantation; molecular genetics of human hemoglobins; gene expression and differentiation in erythroid cells in normal and perturbed hematopoietic states; pharmacological alteration of gene expression; molecular genetics of myleodysplastic and myleoproliferative syndromes; hematopoiesis; role of inducible and stochastic factors; hematopoietic stem cell plasticity; identification of early markers of lineage-specific differentiation; the development of novel gene therapy strategies and their targeted application in cord blood hematopoietic stem cells.
As a research investigator, Dr. Rodgers is widely recognized for his contributions to the development of hydroxyurea, the first effective—and now FDA approved—therapy for sickle cell anemia.
Representative Publications:
Allogeneic hematopoietic stem-cell transplantation for sickle cell disease
HbA2 : biology, clinical relevance and a possible target for ameliorating sickle cell disease
Hemolytic anemia-associated pulmonary hypertension in sickle cell disease
+myBinderRelated Content
-
Elliott Vichinsky, MDElliott Vichinsky, MD diagnoses and trea...
-
Kim Smith-Whitley, MDDr. Smith-Whitley is the director of the...
-
East Carolina University Comprehensive Sickle Cell CenterEast Carolina University Comprehensive S...
-
Home Oxygen Therapy for Children: An Official American Thoracic Society Clinical Practice GuidelineBackground: Home oxygen therapy is ofte...
-
4 Transition Stages of Sickle Cell Disease and Tips for Each Stagehttps://www.onescdvoice.com/wp-content/u...
-
Data Brief: Healthcare Utilization for Vaso-Occlusive Episodes by People with Sickle Cell Disease in California and ...Many people with sickle cell disease (SC...
-
Aflac Cancer and Blood Disorders Center of Children’s Healthcare of AtlantaAs one of the leading pediatric cancer, ...
